Skip to main content
. 2022 Oct 20;10(10):1761. doi: 10.3390/vaccines10101761

Figure 7.

Figure 7

Longitudinal analysis of IgGs related to SARS-CoV-2 against RBD domain of S protein throughout the follow-up of vaccination schedule. Longitudinal analysis by OD of paired samples throughout vaccination scheme (pre-vaccine, first vaccine dose, and second vaccine dose) in COVID-19(−) and recovered COVID-19(+) participants. Central trend values and dispersion values are indicated in Table S8, Supplementary Data.